Journal
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
Volume 13, Issue 5, Pages 532-534Publisher
OXFORD UNIV PRESS
DOI: 10.1510/icvts.2011.276360
Keywords
Valves; Aortic valve; Transcatheter aortic valve implantation; Transapical aortic valve implantation
Ask authors/readers for more resources
BioGlue (CryoLife Inc, Kenneswa, GA, USA), a bovine serum albumin-glutaraldehyde tissue sealant, was at times used to seal the myocardial holes of the polypropylene stitches at the apex of the heart during transapical aortic valve implantation (TAVI). We describe three patients who developed late wound healing problems after TAVI that were thought to be caused by BioGlue. The surgical wound revision was performed on the 115th, 41st and 60th days, respectively, after original TAVI procedures. At revision, a 'foreign body' reaction surrounded by healthy well-vascularized tissue was found. All intraoperative cultures were sterile despite evidence of purulent-like material at the time of wound debridement. The wounds healed 'per primam intentionem' and the patients' postoperative course was also completely uneventful. (C) 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available